Genmab AS (GMAB)
21.67
-0.80
(-3.56%)
USD |
NASDAQ |
Nov 13, 16:00
21.82
+0.15
(+0.69%)
After-Hours: 20:00
Genmab Price: 21.67 for Nov. 13, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2024 | 21.94 | 22.20 | 21.59 | 21.67 | 2.584M |
| Nov 12, 2024 | 22.90 | 22.94 | 22.40 | 22.47 | 1.374M |
| Nov 11, 2024 | 23.18 | 23.47 | 22.95 | 23.20 | 1.654M |
| Nov 08, 2024 | 22.85 | 23.18 | 22.80 | 23.08 | 1.561M |
| Nov 07, 2024 | 22.64 | 23.19 | 22.64 | 23.11 | 1.375M |
| Nov 06, 2024 | 22.20 | 22.76 | 21.90 | 22.33 | 1.847M |
| Nov 05, 2024 | 22.56 | 22.84 | 22.18 | 22.75 | 1.730M |
| Nov 04, 2024 | 22.69 | 22.89 | 22.65 | 22.78 | 1.294M |
| Nov 01, 2024 | 22.60 | 22.63 | 22.52 | 22.56 | 1.113M |
| Oct 31, 2024 | 22.36 | 22.40 | 22.22 | 22.32 | 964928.0 |
| Oct 30, 2024 | 22.69 | 22.82 | 22.56 | 22.57 | 882485.0 |
| Oct 29, 2024 | 23.05 | 23.15 | 22.87 | 23.12 | 1.919M |
| Oct 28, 2024 | 23.08 | 23.21 | 22.95 | 23.14 | 866155.0 |
| Oct 25, 2024 | 22.74 | 23.30 | 22.73 | 23.12 | 2.491M |
| Oct 24, 2024 | 22.82 | 22.98 | 22.78 | 22.82 | 1.035M |
| Oct 23, 2024 | 22.84 | 22.98 | 22.67 | 22.73 | 1.015M |
| Oct 22, 2024 | 22.43 | 22.79 | 22.39 | 22.77 | 1.245M |
| Oct 21, 2024 | 22.76 | 22.80 | 22.54 | 22.78 | 1.591M |
| Oct 18, 2024 | 22.78 | 23.08 | 22.73 | 22.98 | 2.088M |
| Oct 17, 2024 | 22.95 | 22.99 | 22.78 | 22.96 | 1.047M |
| Oct 16, 2024 | 22.83 | 22.85 | 22.52 | 22.60 | 1.331M |
| Oct 15, 2024 | 23.59 | 23.62 | 23.16 | 23.18 | 1.080M |
| Oct 14, 2024 | 23.53 | 23.68 | 23.40 | 23.66 | 3.333M |
| Oct 11, 2024 | 23.54 | 23.75 | 23.45 | 23.53 | 2.008M |
| Oct 10, 2024 | 23.56 | 23.74 | 23.50 | 23.71 | 1.105M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
17.15
Minimum
Mar 16 2020
48.72
Maximum
Sep 03 2021
34.21
Average
35.26
Median
Price Benchmarks
| Novo Nordisk AS | 106.91 |
| Ascendis Pharma AS | 126.03 |
| Galecto Inc | 6.89 |
| Evaxion Biotech AS | 1.72 |
| IO Biotech Inc | 0.97 |
Price Related Metrics
| PE Ratio | 20.59 |
| PS Ratio | 4.889 |
| PEG Ratio | 1.377 |
| Price to Book Value | 2.879 |
| Price to Free Cash Flow | 14.72 |
| Earnings Yield | 4.86% |
| Market Cap | 13.76B |
| PEGY Ratio | 1.377 |
| Operating PE Ratio | 14.95 |
| Normalized PE Ratio | 18.22 |